Table 3. Prevalence of MACCE and Major Bleeding Events during Follow-Up (PTRG-DES: n=13160).

MACCE			Major bleeding
All-cause death		512 (3.9)	BARC type 3		414 (3.1)
	CV death	165 (1.3)		3a	297 (2.3)
	Non-CV death	347 (2.6)		3b	67 (0.5)
				3c	50 (0.4)
Non-fatal MI		201 (1.5)	BARC type 4		7 (0.1)
Stent thrombosis (definite)		69 (0.5)	BARC type 5		10 (0.1)
				5a	3 (0.0)
				5b	7 (0.1)
Non-fatal stroke		238 (1.8)

MACCE, major adverse cardiac and cerebrovascular events; PTRG-DES, Platelet function and genoType-Related long-term proGnosis in Drug-Eluting Stent-treated Patients with coronary artery disease; BARC, Bleeding Academic Research Consortium; CV, cardiovascular; MI, myocardial infarction.

Data are presented as n (%).